Noninvasive validation of central and peripheral augmentation index estimated by a novel wrist-worn tonometer
- 1 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 36 (11) , 2204-2214
Abstract
The validation of new blood pressure devices with easier use and more rapid data collection may facilitate the incorporation of these measures into clinical practice. We analyze the reliability and validity of Pulse Wave Analysis as reported by a novel wrist-worn device, easy and quick to use, comparing central and peripheral augmentation index (AIx) with the same measures from the SphygmoCor. Additionally, we analyzed clinical relevance through the association of the Pulse Wave Analysis, as reported by a novel wrist-worn device, with other cardiovascular parameters. Cross-sectional study including 254 participants. Mean age was 51.9 ± 13.4 years and 53% were women. peripheral AIx (PAIx) and central AIx (CAIx) by the wrist-worn device and SphygmoCor (MM3); carotid-femoral (cf) pulse wave velocity (PWV) by SphygmoCor (MM3); cardioankle-vascular index (CAVI), ankle-brachial index (ABI) and brachial-ankle (ba) PWV by the Vasera device and carotid-intima media thickness (IMT) by ultrasonography. Intra-observer intra-class correlation coefficient (ICC) for PAIx was 0.886 (95% CI 0.803-0.934) and for CAIx 0.943 (95% CI 0.901-0.968) with Bland Altman limits of agreement -0.75 (-23.8 to 21.8) and 0.08 (-15.7 to 15.9), respectively. Inter-observer ICC for PAIx was 0.952 (95% CI 0.915-0.972) and CAIx 0.893 (95% CI 0.811-0.939) with limits of agreement -0.45 (-13.7 to 12.8) and 0.43 (-17.7 to 18.5), respectively. Comparing the wrist-worn device with SphygmoCor, the ICC was 0.849 (95% CI 0.798-0.887) for PAIx, and 0.783 (95% CI 0.711-0.838) for CAIx. In Bland-Altman, limits of agreement for PAIx 1.03 (-20.67 to 22.73), and for CAIx -2.14 (-24.79 to 20.50). PAIx and CAIx, from the wrist-worn device, correlated with age, CAVI, ABI, baPWV, cfPWV, IMT, glomerular filtration and cardiovascular risk. AIx measurements by wrist-worn device shows a good intra-observer and inter-observer reliability, inter-device noninvasive reliability and validity when compared with SphygmoCor, and clinical relevance by association with measures of vascular structure and function, end-organ damage and cardiovascular risk. Clinicaltrials.gov NCT02623894; https://clinicaltrials.gov/ct2/show/NCT02623894.Keywords
This publication has 59 references indexed in Scilit:
- Measurement accuracy of non-invasively obtained central blood pressure by applanation tonometry: A systematic review and meta-analysisInternational Journal of Cardiology, 2013
- Prediction of Cardiovascular Events and All-Cause Mortality With Brachial-Ankle Elasticity IndexHypertension, 2012
- Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocityJournal Of Hypertension, 2012
- Validation of a Brachial Cuff-Based Method for Estimating Central Systolic Blood PressureHypertension, 2011
- Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocityJournal Of Hypertension, 2010
- Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease RiskJACC, 2010
- A new oscillometric method for pulse wave analysis: comparison with a common tonometric methodJournal of Human Hypertension, 2010
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Peripheral Augmentation Index Defines the Relationship Between Central and Peripheral Pulse PressureHypertension, 2008
- Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocityJournal Of Hypertension, 2004